While higher doses (particularly 54 mg) showed some increase in gastrointestinal-related events, these remained mild to moderate in severity and did not result in treatment discontinuation
Tesamorelin acts primarily through the GHRH receptor in the anterior pituitary, while Ipamorelin selectively targets the ghrelin/growth hormone secretagogue receptor, known as GHS-R1a
Laboratory studies using 5-amino-1MQ in aged animal models have revealed that NNMT inhibition modulates many age-associated metabolic parameters, including alterations in muscle tissue metabolism and cellular stress response pathways
Applications encompass investigating aging mechanisms, healthspan extension, and cellular resilience enhancement
V., Shimokawa, T., Nagy, T